Ondansetron HCL Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-R-0017
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation for the procurement of Ondansetron HCL Tablets, as indicated by Solicitation Number SPE2D2-25-R-0017. This opportunity is classified under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, denoting drugs and biologicals. The solicitation is currently active, with a posting date of August 26, 2025, and responses due by September 26, 2025.
The primary objective of this procurement is to secure a reliable supply of Ondansetron HCL Tablets for federal use, ensuring the availability of this critical antiemetic medication for military and associated healthcare operations. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Ondansetron HCL Tablets, adhering to all applicable regulatory standards and quality requirements as detailed in the attached solicitation document.
DLA Troop Support, a federal office, serves as the contracting entity for this requirement. Interested contractors should note that the solicitation and all associated requirements are accessible via the official SAM.gov opportunity listing (Opportunity ID: 73ecb5e9d5b744e99c935d12d7f7e27b). While the specific quantities, packaging, and delivery schedules are outlined in the attached solicitation, contractors are expected to demonstrate compliance with pharmaceutical manufacturing standards and the ability to meet the agency’s logistical and quality assurance needs.
Key contacts for this procurement include Kyle Lewicki ([email protected], 445-737-0977) as the primary point of contact, and Catherine Gilbert ([email protected], 445-737-8868) as the secondary contact. All inquiries and submissions should be directed to these individuals as specified in the solicitation.
This procurement is a formal solicitation; any set-aside requirements or special considerations are detailed within the attached solicitation document. Contractors are encouraged to review the solicitation in full to assess alignment with their manufacturing capabilities, regulatory compliance, and past performance in supplying pharmaceutical products to federal agencies.
Overall, this opportunity represents a significant contract for qualified pharmaceutical manufacturers capable of delivering Ondansetron HCL Tablets in accordance with federal standards and DLA Troop Support’s operational requirements.